- The Chemoenzymatic Synthesis of 2-Chloro- and 2-Fluorocordycepins
-
Two approaches to the chemoenzymatic synthesis of 2-fluorocordycepin and 2-chlorocordycepin were studied: (i) the use of 3′-deoxyadenosine (cordycepin) and 3′-deoxyinosine (3′dIno) as donors of 3-deoxy- d -ribofuranose in the transglycosylation of 2-fluoro- (2F Ade) and 2-chloroadenine (2Cl Ade) catalyzed by the recombinant E. coli purine nucleoside phosphorylase (PNP), and (ii) the use of 2-fluoroadenosine and 3′-deoxyinosine as substrates of the cross-glycosylation and PNP as a biocatalyst. An efficient method for 3′-deoxyinosine synthesis starting from inosine was developed. However, the very poor solubility of 2Cl Ade and 2F Ade is the limiting factor of the first approach. The second approach enables this problem to be overcome and it appears to be advantageous over the former approach from the viewpoint of practical synthesis of the title nucleosides. The 3-deoxy-α- d -ribofuranose-1-phosphate intermediary formed in the 3′dIno phosphorolysis by PNP was found to be the weak and marginal substrate of E. coli thymidine (TP) and uridine (UP) phosphorylases, respectively. Finally, one-pot cascade transformation of 3-deoxy- d -ribose in cordycepin in the presence of adenine and E. coli ribokinase, phosphopentomutase, and PNP was tested and cordycepin formation in ca. 3.4% yield was proved.
- Denisova, Alexandra O.,Tokunova, Yulia A.,Fateev, Ilja V.,Breslav, Alexandra A.,Leonov, Vladimir N.,Dorofeeva, Elena V.,Lutonina, Olga I.,Muzyka, Inessa S.,Esipov, Roman S.,Kayushin, Alexey L.,Konstantinova, Irina D.,Miroshnikov, Anatoly I.,Stepchenko, Vladimir A.,Mikhailopulo, Igor A.
-
p. 4853 - 4860
(2017/10/06)
-
- NEW 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS
-
The present invention relates to chemical compounds, the compounds for use in a method of treatment, particularly in a method of prophylaxis or treatment for cancer, a process for preparation of the compounds and pharmaceutical compositions comprising the compounds. The compounds may, in particular, be useful in the treatment of leukaemia, lymphoma and/or solid tumours inhomo sapiens. The compounds are derivatives of cordycepin (3'-deoxyadenosine) having a 2' and/or 5'- amino-acid ester phosphoramidate moeity.
- -
-
-
- Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis
-
Novel methods for treatment of African trypanosomiasis, caused by infection with Trypanosoma brucei are needed. Cordycepin (3′-deoxyadenosine, 1a) is a powerful trypanocidal compound in vitro but is ineffective in vivo because of rapid metabolic degradation by adenosine deaminase (ADA). We elucidated the structural moieties of cordycepin required for trypanocidal activity and designed analogues that retained trypanotoxicity while gaining resistance to ADA-mediated metabolism. 2-Fluorocordycepin (2-fluoro-3′-deoxyadenosine, 1b) was identified as a selective, potent, and ADA-resistant trypanocidal compound that cured T. brucei infection in mice. Compound 1b is transported through the high affinity TbAT1/P2 adenosine transporter and is a substrate of T. b. brucei adenosine kinase. 1b has good preclinical properties suitable for an oral drug, albeit a relatively short plasma half-life. We present a rapid and efficient synthesis of 2-halogenated cordycepins, also useful synthons for the development of additional novel C2-substituted 3′-deoxyadenosine analogues to be evaluated in development of experimental therapeutics.
- Vodnala, Suman K.,Lundb?ck, Thomas,Yeheskieli, Esther,Sj?berg, Birger,Gustavsson, Anna-Lena,Svensson, Richard,Olivera, Gabriela C.,Eze, Anthonius A.,De Koning, Harry P.,Hammarstr?m, Lars G. J.,Rottenberg, Martin E.
-
p. 9861 - 9873
(2014/01/17)
-
- Chemo-enzymatic synthesis of 3-deoxy-β-D-ribofuranosyl purines and study of their biological properties
-
9-(3-Deoxy-β-D-erythro-pentofuranosyl)-2,6-diaminopurine (2) was synthesized by an enzymatic transglycosylation of 2,6-diaminopurine using 3′-deoxycytidine (1) as a donor of the sugar moiety. Nucleoside 2 was transformed to 3′-deoxy guanosine (3), 9-(3-deoxy-β -D-erythro-pentofuranosyl)-2-amino-6-oxopurine (3′-deoxyisoguanosine; 4), and 9-(3-deoxy-β-D-erythro- pentofuranosyl)-2-fluoroadenine (5). Compounds 2-5 were evaluated for their anti-HIV activity.
- Barai, Vladimir N.,Zinchenko, Anatoli I.,Eroshevskaya, Ludmilla A.,Zhernosek, Elena V.,Balzarini, Jan,De Clercq, Erik,Mikhailopulo, Igor A.
-
p. 751 - 753
(2007/10/03)
-
- Chemo-enzymatic synthesis of 3-deoxy-β-D-ribofuranosyl purines
-
9-(3-Deoxy-β-D-erythro-pentofuranosyl)-2,6-diaminopurine (6) was synthesized by an enzymatic transglycosylation of 2,6-diaminopurine (2) with 3′-deoxycytidine (1) as a donor of 3-deoxy-D-erythro-pentofuranose moiety. This transformation comprises i) deamination of 1 to 3′-deoxyuridine (3) under the action of whole cell (E. coli BM-11) cytidine deaminase (CDase), ii) the phosphorolytic cleavage of 3 by uridine phosphorylase (UPase) giving rise to the formation of uracil (4) and 3-deoxy-α-D-erythro-pentofuranose-1-O-phosphate (5), and iii) coupling of the latter with 2 catalyzed by whole cell (E. coli BMT-4D/1A) purine nucleoside phosphorylase (PNPase). Deamination of 6 by adenosine deaminase (ADase) gave 3′-deoxyguanosine (7). Treatment of 6 with NaNO2 afforded 9-(3-deoxy-β-D-erythro-pentofuranosyl)-2-amino-6-oxopurine (3′-deoxyisoguanosine; 8). Schiemann reaction of 6 (HF/HBF4 + NaNO2) gave 9-(3-deoxy-β-D-erythro-pentofuranosyl)-2-fluoroadenine (9).
- Barai, Vladimir N.,Zinchenko, Anatoli I.,Eroshevskaya, Ludmilla A.,Zhernosek, Elena V.,De Clercq, Erik,Mikhailopulo, Igor A.
-
p. 1893 - 1900
(2007/10/03)
-